165 related articles for article (PubMed ID: 12218163)
41. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Weidmann E; Whiteside TL; Giorda R; Herberman RB; Trucco M
Cancer Res; 1992 Nov; 52(21):5913-20. PubMed ID: 1382847
[TBL] [Abstract][Full Text] [Related]
42. Analysis of T cell receptor variable regions and complementarity determining region 3 of infiltrating T lymphocytes in the liver of patients with chronic type B hepatitis.
Maru Y; Yokosuka O; Imazeki F; Saisho H; Omata M
Intervirology; 2003; 46(5):277-88. PubMed ID: 14555848
[TBL] [Abstract][Full Text] [Related]
43. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis.
Sakkas LI; Xu B; Artlett CM; Lu S; Jimenez SA; Platsoucas CD
J Immunol; 2002 Apr; 168(7):3649-59. PubMed ID: 11907131
[TBL] [Abstract][Full Text] [Related]
44. An analysis of T-cell-receptor variable-region genes in tumor-infiltrating lymphocytes within malignant tumors.
Nitta T; Sato K; Okumura K; Steinman L
Int J Cancer; 1991 Oct; 49(4):545-50. PubMed ID: 1655662
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells.
Lin C; Chen S; Yang L; Tan Y; Bai X; Li Y
Hematology; 2007 Aug; 12(4):325-30. PubMed ID: 17654060
[TBL] [Abstract][Full Text] [Related]
46. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
Yazdi AS; Morstedt K; Puchta U; Ghoreschi K; Flaig MJ; Rocken M; Sander CA
J Invest Dermatol; 2006 Feb; 126(2):393-8. PubMed ID: 16374454
[TBL] [Abstract][Full Text] [Related]
47. Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine.
Berd D; Maguire HC; Mastrangelo MJ; Murphy G
Cancer Immunol Immunother; 1994 Sep; 39(3):141-7. PubMed ID: 7923243
[TBL] [Abstract][Full Text] [Related]
48. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
[TBL] [Abstract][Full Text] [Related]
49. The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen.
Li Y; Yang L; Chen S; Zhang Y; Wu X
Hematology; 2005 Oct; 10(5):387-92. PubMed ID: 16273727
[TBL] [Abstract][Full Text] [Related]
50. Distinct control of the frequency and allelic exclusion of the V beta gene rearrangement at the TCR beta locus.
Sieh P; Chen J
J Immunol; 2001 Aug; 167(4):2121-9. PubMed ID: 11489996
[TBL] [Abstract][Full Text] [Related]
51. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
[TBL] [Abstract][Full Text] [Related]
52. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
53. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
[TBL] [Abstract][Full Text] [Related]
54. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
[TBL] [Abstract][Full Text] [Related]
55. Characterization of conserved CDR3 sequence of TCR alpha- and beta-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma.
Yin Q; Tan H; Chen S; Yang L; Ye J; Li Y
Hematology; 2010 Feb; 15(1):48-57. PubMed ID: 20132663
[TBL] [Abstract][Full Text] [Related]
56. Evidence of T cell clonality in the infectious tolerance pathway: implications toward identification of regulatory T cells.
Zhai Y; Li J; Hammer M; Busuttil RW; Volk HD; Kupiec-Weglinski JW
Transplantation; 2001 Jun; 71(12):1701-8. PubMed ID: 11455246
[TBL] [Abstract][Full Text] [Related]
57. Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition.
Moore TV; Lyons GE; Brasic N; Roszkowski JJ; Voelkl S; Mackensen A; Kast WM; Le Poole IC; Nishimura MI
Cancer Immunol Immunother; 2009 May; 58(5):719-28. PubMed ID: 18836717
[TBL] [Abstract][Full Text] [Related]
58. T cell receptor Vbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia.
Li YQ; Yang LJ; Chen SH; Zhang YP; Zhang XL; Luo GX
Chin Med J (Engl); 2004 Jun; 117(6):840-3. PubMed ID: 15198883
[TBL] [Abstract][Full Text] [Related]
59. Complementarity-determining region 1 sequence requirements drive limited V alpha usage in response to influenza hemagglutinin 307-319 peptide.
Brawley JV; Concannon P
J Immunol; 2002 Apr; 168(8):3894-901. PubMed ID: 11937544
[TBL] [Abstract][Full Text] [Related]
60. T cell receptor β-chain repertoire analysis of tumor-infiltrating lymphocytes in pancreatic cancer.
Cui C; Tian X; Wu J; Zhang C; Tan Q; Guan X; Dong B; Zhao M; Lu Z; Hao C
Cancer Sci; 2019 Jan; 110(1):61-71. PubMed ID: 30426614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
